Predicting response to neoadjuvant chemotherapy in nonmetastatic hormone receptor-positive breast cancer using 21-gene Breast Recurrence Score test.

Romy Jose Thekkekara,Sushma Bharadwaj,Udit Yadav,Anmol Baranwal,David F. Peace,Wendy Rogowski,Marin Sekosan,Thomas E. Lad,Elizabeth A. Marcus,Karen Ferrer,Mousami Shah,Susan McDunn

Predicting response to neoadjuvant chemotherapy in nonmetastatic hormone receptor-positive breast cancer using 21-gene Breast Recurrence Score test.

2019

Romy Jose Thekkekara
Sushma Bharadwaj
Udit Yadav
Anmol Baranwal
David F. Peace
Wendy Rogowski
Marin Sekosan
Thomas E. Lad
Elizabeth A. Marcus
Karen Ferrer
Mousami Shah
Susan McDunn

e12093Background: The Recurrence Score (RS) result based on the 21-gene Oncotype DX Breast Recurrence Score assay is standard of care in deciding adjuvant chemo-hormonal therapy versus hormone ther...

Keywords:

Hormone receptor
Oncology
Breast cancer
Adjuvant
Score test
Pathology
Oncotype DX
Hormone
Chemotherapy
Medicine
Internal medicine
standard of care
recurrence score

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations